These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21737366)

  • 21. Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1.
    Gonsorcíková L; Průhová S; Cinek O; Ek J; Pelikánová T; Jørgensen T; Eiberg H; Pedersen O; Hansen T; Lebl J
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):367-72. PubMed ID: 18331410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Clinical Indices to Distinguish MODY2 (GCK Mutation) and MODY3 (HNF1A Mutation) from Type 1 Diabetes in a Young Chinese Population.
    Fu J; Wang T; Liu J; Wang X; Zhang Q; Li M; Xiao X
    Diabetes Ther; 2019 Aug; 10(4):1381-1390. PubMed ID: 31214998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A Dutch family with an autosomal dominant form of diabetes mellitus as a result of a mutation in the HNF1 alpha-gene (MODY3)].
    Tack CJ; Hattersley AT
    Ned Tijdschr Geneeskd; 1998 Oct; 142(41):2252-6. PubMed ID: 9864503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype.
    Furuzawa GK; Giuffrida FM; Oliveira CS; Chacra AR; Dib SA; Reis AF
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e12-4. PubMed ID: 18672310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3).
    Yamagata K; Oda N; Kaisaki PJ; Menzel S; Furuta H; Vaxillaire M; Southam L; Cox RD; Lathrop GM; Boriraj VV; Chen X; Cox NJ; Oda Y; Yano H; Le Beau MM; Yamada S; Nishigori H; Takeda J; Fajans SS; Hattersley AT; Iwasaki N; Hansen T; Pedersen O; Polonsky KS; Bell GI
    Nature; 1996 Dec; 384(6608):455-8. PubMed ID: 8945470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.
    Schober E; Rami B; Grabert M; Thon A; Kapellen T; Reinehr T; Holl RW;
    Diabet Med; 2009 May; 26(5):466-73. PubMed ID: 19646184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity.
    Hattersley AT
    Diabet Med; 1998 Jan; 15(1):15-24. PubMed ID: 9472859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young.
    Ellard S
    Hum Mutat; 2000 Nov; 16(5):377-85. PubMed ID: 11058894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic diabetic complications in patients with MODY3 diabetes.
    Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L
    Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes mellitus].
    Iwasaki N
    Rinsho Byori; 2001 Feb; 49(2):161-4. PubMed ID: 11307309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical application of best practice guidelines for the genetic diagnosis of MODY2 and MODY3.
    Incani M; Cambuli VM; Cavalot F; Congiu T; Paderi M; Sentinelli F; Romeo S; Poy P; Soro M; Pilia S; Loche S; Cossu E; Trovati M; Mariotti S; Baroni MG
    Diabet Med; 2010 Nov; 27(11):1331-3. PubMed ID: 20950394
    [No Abstract]   [Full Text] [Related]  

  • 33. Large Family With Maturity-Onset Diabetes of the Young and a Novel V121I Mutation in HNF4A.
    Monney CT; Kaltenrieder V; Cousin P; Bonny C; Schorderet DF
    Hum Mutat; 2002 Sep; 20(3):230-1. PubMed ID: 12203996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maturity-onset diabetes of the young: an update.
    Olek K
    Clin Lab; 2006; 52(11-12):593-8. PubMed ID: 17175890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database.
    Awa WL; Schober E; Wiegand S; Herwig J; Meissner T; Schmidt F; Molz E; Holl RW
    Diabetes Res Clin Pract; 2011 Dec; 94(3):463-7. PubMed ID: 21955960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mature onset diabetes of the young (MODY)].
    Nobre EL; Lopes LO; Miranda A; Pragosa M; de Castro JJ
    Acta Med Port; 2002; 15(6):435-9. PubMed ID: 12680290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
    Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
    Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age.
    Odem J; Munzinger E; Violand S; Van Morlan A; Rife D; Bachrach B
    Pediatr Diabetes; 2009 Dec; 10(8):550-3. PubMed ID: 19515026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [MODY 3 correlations between the genotype and clinical manifestations of diabetes].
    Simonella G; Pianese L; Vichi G; Staffolani P; Morosini P
    Recenti Prog Med; 2011 Oct; 102(10):387-91. PubMed ID: 21989397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3.
    Bellanné-Chantelot C; Carette C; Riveline JP; Valéro R; Gautier JF; Larger E; Reznik Y; Ducluzeau PH; Sola A; Hartemann-Heurtier A; Lecomte P; Chaillous L; Laloi-Michelin M; Wilhem JM; Cuny P; Duron F; Guerci B; Jeandidier N; Mosnier-Pudar H; Assayag M; Dubois-Laforgue D; Velho G; Timsit J
    Diabetes; 2008 Feb; 57(2):503-8. PubMed ID: 18003757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.